What is the Y-tunnus number of Nordic Drugs AB, filial i Finland?

Nordic Drugs AB, filial i Finland is registered with PRH / YTJ under Y-tunnus 1572025-4.

What is the revenue of Nordic Drugs AB, filial i Finland?

Nordic Drugs AB, filial i Finland reported revenue of EUR 10,2M in 2025.

How many employees does Nordic Drugs AB, filial i Finland have?

Nordic Drugs AB, filial i Finland employs 25 people as of the latest annual report.

Who is the CEO of Nordic Drugs AB, filial i Finland?

Arnaud Etienne is Foreign representative of Nordic Drugs AB, filial i Finland, in role since 2020.

Where is Nordic Drugs AB, filial i Finland headquartered?

Nordic Drugs AB, filial i Finland's registered address is C/O World Trade Center Alexandersgatan 17.

Riskpilot← Back to search

Sign inGet full access

Nordic Drugs AB, filial i Finland

SLActive

Y-tunnus 1572025-4C/O World Trade Center Alexandersgatan 17, 00100 HelsingforsWholesale of pharmaceutical and medical goods · NACE 4646Est. 1999 · 26 years old25 employees

Overview Financials People & ownership Related companies

Financials

Revenue

EUR millions

EBITDA

EUR millions

Income statement

EUR thousands

Item	2019	2022	2023	2024	2025
Revenue	4 968	6 087	7 267	0	10 190
Staff expenses	−603	−535	−619	−726	−922
EBITDA	655	861	1 101	−1 995	1 588
Depreciation & amort.	−1	−0	−0	−0	−0
EBIT	654	861	1 101	−1 995	1 588
Net financials	—	1	9	−3	8
Profit before tax	654	862	1 110	−426	1 596
Tax	132	172	222	−0	319
Net profit	522	690	888	−426	1 276

Balance sheet

EUR thousands

Item	2019	2022	2023	2025
Total assets	3 868	5 321	6 394	9 195
Equity	3 097	4 778	4 778	8 370
Long-term debt	—	—	0	0
Short-term debt	771	543	193	825
Total debt	771	543	728	825

Financial ratios

5-year trend

EBITDA margin

15.6%

This company

15.8%

Market median

+1% vs market

20192025

Equity ratio

91.0%

This company

38.2%

Market median

+138% vs market

20192025

Return on equity

15.2%

This company

18.4%

Market median

+17% vs market

20192025

Net profit margin

12.5%

This company

8.1%

Market median

+54% vs market

20192025

Asset turnover

1.11×

This company

1.12×

Market median

+1% vs market

20192025

Debt / equity

0.10×

This company

0.62×

Market median

+84% vs market

20192025

Annual reports & filings

Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2019
Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
View PDF

Nordic Drugs AB, filial i Finland

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Nordic Drugs AB, filial i Finland

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Nordic Drugs AB, filial i Finland